| # | Drug | Count |
|---|---|---|
| 0 | TEPROTUMUMAB | 185 |
| 1 | PREDNISONE | 123 |
| 2 | METHOTREXATE SODIUM | 96 |
| 3 | LEVOTHYROXINE SODIUM | 90 |
| 4 | METHOTREXATE | 87 |
| 5 | OMEPRAZOLE MAGNESIUM | 73 |
| 6 | METHYLPREDNISOLONE | 69 |
| 7 | IBUPROFEN | 65 |
| 8 | ERGOCALCIFEROL | 64 |
| 9 | ASPIRIN | 60 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TEPROTUMUMAB | 185 | 0.0311 |
| 1 | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | 2 | 0.0235 |
| 2 | ALMOTRIPTAN | 12 | 0.0113 |
| 3 | DIHYDROERGOTAMINE MESYLATE | 11 | 0.0082 |
| 4 | PIMOZIDE | 3 | 0.0062 |
| 5 | AVACINCAPTAD PEGOL | 2 | 0.0057 |
| 6 | PROPYLTHIOURACIL | 10 | 0.0048 |
| 7 | NEOSTIGMINE METHYLSULFATE | 2 | 0.0046 |
| 8 | .ALPHA.-TOCOPHEROL ACETATE, DL-, ASCORBIC ACID, CYANOCOBALAMIN, FOLIC ACID, NIACIN, PYRIDOXINE, RIBOFLAVIN, SODIUM FLUORIDE, THIAMINE MONONITRATE, VITAMIN A AND VITAMIN D | 1 | 0.0045 |
| 9 | POVIDONE-IODINE | 19 | 0.0044 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 310 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 193 |
| 2 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 185 |
| 3 | Benzodiazepine [EPC] | 123 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 88 |
| 5 | Proton Pump Inhibitor [EPC] | 82 |
| 6 | Vitamin C [EPC] | 72 |
| 7 | Provitamin D2 Compound [EPC] | 64 |
| 8 | Platelet Aggregation Inhibitor [EPC] | 61 |
| 9 | Osmotic Laxative [EPC] | 59 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Endoglycosidase [EPC] | 25 | 0.0135 |
| 1 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 2 | Thyroid Hormone Synthesis Inhibitor [EPC] | 43 | 0.0044 |
| 3 | Antiseptic [EPC] | 19 | 0.0043 |
| 4 | Interleukin-6 Antagonist [EPC] | 2 | 0.0031 |
| 5 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 6 | CD52-directed Cytolytic Antibody [EPC] | 42 | 0.0022 |
| 7 | Provitamin D2 Compound [EPC] | 64 | 0.0022 |
| 8 | CD38-directed Cytolytic Antibody [EPC] | 12 | 0.0021 |
| 9 | Plasma Volume Expander [EPC] | 6 | 0.0019 |